Introduction
MTAR Technologies has become one of the most talked-about stocks in the Indian market. The numbers tell you why. The stock surged nearly 345% over the past year and rallied 200% in 2026 alone. But behind the price action lies a real business story—one of precision engineering, global clean energy tailwinds, and India’s strategic manufacturing ambitions.
The company builds components where tolerances are measured in microns—one-thousandth of a milli meter. It supplies cryogenic fuel systems for ISRO’s space program, nuclear components for NPCIL, actuators for defense platforms, and fuel cell assemblies for Bloom Energy that power Oracle’s AI data centers. For most of the past decade, MTAR operated under the radar. That has changed dramatically.
The central question for investors today is straightforward: can MTAR deliver on its ambitious FY27 guidance of 80% revenue growth? Let’s dig into the numbers, the drivers, the risks, and what this means for different types of investors.
What MTAR Actually Does
Before we talk about growth, we need to understand the business. MTAR Technologies is a precision engineering company that manufactures mission-critical components and systems. The company operates across five key segments: Civil Nuclear Power, Space, Defense & Aerospace, Clean Energy, and Ball Screws & Roller Screws.
What makes MTAR different from most manufacturing companies is the nature of its work. Nuclear vendor approvals alone can take five to seven years. Aerospace relationships are built over years of trust before meaningful production begins. Once MTAR is embedded in a customer’s supply chain, switching suppliers is not just inconvenient—it is often impractical. This creates a powerful competitive moat.
The company’s customer list reads like a who’s who of strategic sectors: ISRO, NPCIL, Bloom Energy, and global defense firms including Israeli companies. MTAR does not compete primarily on price. It competes on irreplaceability.
The FY27 Guidance: From 50% to 80%
In February 2026, MTAR’s management guided for around 50% revenue growth in FY27. By May 2026, that guidance was raised to 80%. What changed in those three months?
The answer lies in the order book. During Q4FY26, MTAR received record order inflows worth ₹2,453.3 crore. Then came the big one—an international order worth $238.76 million, or nearly ₹2,279 crore, from an undisclosed customer. Following this win, the company’s order book expanded to ₹4,896 crore, bringing it close to its FY27 target of ₹5,000 crore.
Managing Director Srinivas Reddy explained the rationale behind the upgrade: “Based on the kind of inputs we received and the order book we have, we reviewed everything very carefully and raised the guidance to a level that is very comfortable and achievable for us”.
The company also guided for FY27 EBITDA margins of 24%, up from 19.5% in FY26. This margin expansion is expected to come from improving operating leverage as revenue scales up.
The Clean Energy Engine
Clean energy is MTAR’s biggest growth driver. The company supplies hot box assemblies—the central operating units of Bloom Energy’s solid oxide fuel cell systems. Bloom Energy’s technology has found itself at the center of one of the most urgent infrastructure problems on the planet: powering AI data centers.
Oracle has signed an agreement to procure up to 2.8 gigawatts of Bloom’s fuel cell systems. Bloom also signed a major deal with AEP, driven by AI data center demand. Motilal Oswal estimates that the Oracle-Bloom partnership could translate into ₹14,000-17,000 crore of incremental orders for MTAR—1.6 to 1.8 times its FY26 revenue.
As of 31 March 2026, MTAR’s order book of ₹2,581.9 crore was distributed as follows: Clean Energy – Fuel Cell, Hydel and Others accounted for 51.2%, Civil Nuclear Power for 26.3%, Aerospace & Defense for 14%, and Products & Others for 8.5%. Clean energy clearly dominates.
The global fuel cell market is expected to expand at a 26.3% CAGR from 2025 to 2030. Bloom Energy itself projects 30-35% compound annual revenue growth through 2030. MTAR’s clean energy revenue is set to ride these tailwinds.
The Diversification Story
While clean energy gets most of the attention, MTAR is not a one-trick pony. The company is seeing substantial growth across aerospace, defense, and nuclear businesses.
In aerospace, MTAR has qualified for many assemblies and is already doing volume production. The company supplies precision-engineered assemblies for domestic defense Programes and other applications. In defense, it manufactures gearboxes, actuation systems, aerostructures, and ball screws. In nuclear, it provides complex assemblies including fuel machining heads, drive mechanisms, bridge and column assemblies, and coolant channel assemblies.
Reddy noted: “If you look at the absolute numbers, all our other growth engines, like aerospace, nuclear, oil and gas, is kicking in right now, they are growing in the absolute numbers very well year-on-year basis”.
Five years down the line, clean energy should contribute around 60-65% of overall revenue, while the remaining 35-40% will come from the company’s other businesses. This diversification is important for reducing customer concentration risk.
The Order Book Momentum
Ordering activity has remained strong and is expected to gather further momentum in the coming quarters. The company has already received substantial orders during the quarter, more than ₹2,800 crore.
As of March 2026, the order book stood at around ₹2,600 crore. After the ₹2,279 crore international order, it expanded to ₹4,896 crore. The company expects to reach approximately ₹5,000 crore by the end of FY27.
This order book provides strong revenue visibility. The company has clear visibility for the next five to six years. The challenge is not finding customers—it is building enough capacity to serve them.
Capacity Expansion: The Execution Challenge
With a massive order book comes the challenge of execution. MTAR is expanding manufacturing capacities during the year to support execution across clean energy, aerospace, defense, and nuclear businesses.
The company is executing a three-phase expansion: 12,000 units by March 2026, 20,000 by December 2026, and 30,000 by FY28. From an initial capacity of 8,000 units, the company plans to double to 16,000 units by the end of FY27 and eventually scale to 30,000 units.
MTAR is planning ₹250-300 crore of capital expenditure during FY27, partly funded through debt, to support future growth and capacity expansion. The company estimates that incremental capex of ₹500-700 crore would be required to reach ₹5,000 crore revenue by FY30.
Existing capacity expansions have already been commissioned, and the company is undertaking further capacity additions to meet customer requirements. Reddy confirmed that the company has enough capacity to execute the targeted order book.
Financial Performance: The Numbers That Matter
MTAR’s recent financial performance provides the foundation for its growth guidance.
For Q4FY26, the company reported revenue of ₹306 crore, a 67% year-on-year increase. EBITDA margin expanded 154 basis points to 20.19%. Net profit was ₹44 crore, up from ₹14 crore in the corresponding quarter last year—a jump of over 200%.
For the full year FY26, revenue grew 30% year-on-year to ₹876 crore. EBITDA rose 41.7% to ₹171 crore. Net profit increased 76.2% to ₹94 crore. Annual revenue from operations rose around 31% to ₹876.21 crore compared with ₹675.99 crore in the previous year.
The company’s total expenses for the March quarter increased to ₹262.92 crore from ₹164.50 crore in the corresponding period. Cost of materials consumed rose to ₹165 crore from ₹95.66 crore, reflecting higher manufacturing activity. Employee benefit expenses also increased to ₹43.05 crore from ₹34.51 crore.
Quarterly profit before tax margin improved to around 18.4% from 10.2% a year earlier, indicating stronger operational efficiency despite higher costs.
Brokerage Views and Analyst Expectations
Motilal Oswal has been one of the most bullish voices on MTAR. The brokerage maintained a ‘Buy’ rating with a price target of ₹8,000 after the ₹2,279 crore order win. It increased its FY27 and FY28 earnings estimates by 5% and 11%, respectively, citing strong revenue visibility and improving profitability.
Motilal Oswal expects MTAR Technologies to deliver a compound annual growth rate (CAGR) of 67% in revenue, 86% in EBITDA, and 105% in adjusted profit after tax between FY26 and FY28. The brokerage had earlier forecast a revenue/EBITDA/PAT CAGR of 49%/65%/90% over FY25-FY28.
The stock currently trades at 92 times estimated FY27 earnings. Analysts point out that MTAR is trading at stretched valuation multiples, with its price-to-earnings ratio far exceeding sector peers. This sharp re-rating has largely priced in optimistic assumptions around future growth, leaving little margin for disappointment.
The Valuation Question
Let’s address the elephant in the room. MTAR trades at roughly 232 times earnings. The forward PE is around 113.83. Guru Focus analysis suggests the stock appears to be overvalued, with the current price trading 154.8% above its estimated GF Value.
The WACC is 16.51%, 39% above its 10-year median. The financial strength rating is 6 out of 10, 14% below its 10-year median. The operating margin of 17.42% is 21% below its 10-year median of 22.11%.
The stock’s 52-week range tells the story of extreme volatility: a low of ₹1,391 in August 2025 and a high of ₹8,447.95 in May 2026. That’s a six-fold move in nine months.
The odd thing is not that MTAR is a good business. The odd thing is that its valuation has nothing to do with what it does on a Tuesday morning. The stock is priced for perfection. Any disappointment—a delayed order, a paused data centre project, a margin miss—could trigger sharp corrections.
Key Risks to Consider
Customer Concentration:
MTAR derives an estimated 55-65% of its revenue from Bloom Energy. Any slowdown in Bloom’s fuel cell deployment pipeline feeds directly into MTAR’s order book and revenue visibility. When Crusoe paused work on a major AI data center project in June 2026, MTAR’s stock dropped 13%. The stock later rebounded on clarity that the Wyoming project remained on track, but the incident highlighted the risk of customer concentration.
Execution Risk:
With an 80% growth target, MTAR needs to execute flawlessly. Capacity expansion, supply chain management, and quality control at scale are non-trivial challenges. Any execution misstep could derail the growth trajectory.
Valuation Risk:
At current valuations, the stock has little margin for error. If growth falls short of expectations—even slightly—the stock could correct sharply.
Geopolitical Risk:
MTAR supplies components to Israeli defense companies. The ongoing West Asia crisis could create supply-side risks or pressure on margins.
Input Cost Pressure:
The company faces input cost pressures. If raw material costs rise faster than expected, margins could be squeezed.
Investment Scenario Analysis
Best Case
MTAR delivers 80% revenue growth in FY27 with 24% EBITDA margins. The order book reaches ₹5,000 crore. The Bloom Energy relationship deepens, with additional orders from Oracle’s data center build-out. Aerospace, defense, and nuclear segments grow faster than expected. Motilal Oswal’s CAGR projections prove accurate. The stock continues to reward long-term holders despite valuation concerns.
Base Case
MTAR delivers 70-75% revenue growth in FY27, slightly below the 80% guidance. EBITDA margins reach 23-24%. The order book reaches ₹4,500-4,800 crore. Clean energy remains the dominant driver, while other segments grow steadily. The stock trades within a wide range, with volatility driven by news flow around Bloom Energy and data centre projects.
Worst Case
A major Bloom Energy customer pauses or cancels a data center project. Order inflows slow down. MTAR misses its 80% growth target. Margins come under pressure from input costs or execution issues. The stock corrects sharply from current levels as the valuation premium unwinds. Customer concentration risk materialises in the worst possible way.
Who Should Consider This Stock?
Long-term investors who can withstand volatility and have a 5-10 year horizon may find MTAR attractive. The company is positioned at the intersection of multiple structural growth themes: clean energy, AI infrastructure, nuclear power, and defense manufacturing. The competitive moat is real and durable.
Growth investors will be drawn to the 80% revenue growth guidance and Motilal Oswal’s 67% revenue CAGR projection. The growth story is compelling, provided execution stays on track.
Dividend investors should look elsewhere. MTAR does not pay dividends. This is a growth stock, not an income stock.
High-risk investors with a high tolerance for volatility may find MTAR appealing. The stock has already demonstrated extreme price movements. The potential upside is significant, but so is the downside risk.
Conclusion
MTAR Technologies is a remarkable business. The company builds components that few others in the world can manufacture. Its customers cannot easily switch suppliers. The structural tailwinds—clean energy, AI data centers, nuclear power, defense modernisation—are powerful and long-lasting.
The FY27 growth trajectory of 80% revenue growth is ambitious but not unrealistic. The order book provides strong visibility. The capacity expansion plans are well underway. The management team has demonstrated confidence in its guidance.
But the valuation is the wild card. At 232 times trailing earnings, the stock is priced for perfection. The customer concentration risk is real. The execution risk is real. The valuation risk is real.
For investors who believe in the long-term story and can tolerate significant volatility, MTAR offers exposure to some of the most important growth themes of our time. For investors who are uncomfortable with extreme valuations or customer concentration, there are safer places to park capital.
The company has clear visibility for the next five to six years. The question is not whether MTAR will grow—it almost certainly will. The question is whether the stock price already reflects that growth, and then some.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. Stock market investments are subject to market risks. Please conduct your own research or consult a registered financial advisor before making any investment decisions. The author may or may not hold a position in the stocks discussed.
Leave a Reply